Report: PSE legislation proposal hits Jefferson County, Mo.
HILLSBORO, Mo. It started with two municipalities in neighboring Franklin County, and now Jefferson County, located just outside St. Louis, similarly has proposed to require prescriptions for the common cough-cold remedy pseudoephedrine in an attempt to curb methamphetamine production, The St. Louis Post-Dispatch reported Tuesday.
County executives recently voted unanimously to require prescriptions for over-the-counter medications containing the decongestant pseudoephedrine in the first of three readings the bill must pass before it can become law. If passed, the legislation would become binding for nine of the county’s 32 pharmacies, County Executive Ed Kemp told the paper. The other pharmacies fall within unincorporated areas.
Mintel: Cough-cold remedy sales on the rise
CHICAGO Sales of cough-cold remedies will total more than $3.6 billion in 2009, up 1.7% from last year, thanks in large part to the H1N1 pandemic, market research firm Mintel announced Thursday. And drug stores and supermarkets could see sales increases well into the double-digits through the remainder of the cold-and-flu season, Mintel projected.
“The U.S. cold, cough and throat remedy market saw a 13.4% spike in sales during 2005, when the avian flu dominated media stories,” stated Diana Nhan, senior market analyst for Mintel’s Global Market Navigator. “Already, swine flu has received equivalent media exposure, and many Americans are worried about the virus. I wouldn’t be surprised to see a similar trend-busting increase in U.S. cold, cough and throat remedy sales for 2009 and the early part of 2010.”
Americans dedicate more funds towards treating cold-like illnesses than people in the U.K., China or Russia, Mintel stated. In the U.S., all OTC medicine sales account for 0.22% of GDP, compared to 0.2% in Russia and approximately 0.17% in the U.K. and China.
Drive Medical EVP new business development shifts to CEO post
PORT WASHINGTON, N.Y. Less than three months after joining Drive Medical, Vic Mazzacone has been appointed the company’s CEO retail division.
Mazzacone will be responsible for directing and managing the sales and marketing strategy for Drive Medical’s retail division, the company said last week.
Thomas Reynolds, Drive Medical’s president of the retail division, will continue in his current role and will report directly to Mazzacone.
In August, Mazzacone joined Drive Medical as its EVP new business development.